Shanghai MicroPort MedBot (Group) Co., Ltd. Class H Statistics
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (SMMBF) Stock Statistics & Valuation Metrics
Total Valuation
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H has a market cap or net worth of $2.80B. The enterprise value is $24.84B.
- Market Cap
- $2.80B
- Enterprise Value
- $24.84B
Share Statistics
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H has 1,030,720,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,030,720,600
- Owned by Insiders
- ―
- Owned by Institutions
- 4.36%
Financial Efficiency
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s return on equity (ROE) is -0.61 and return on invested capital (ROIC) is -25.22%.
- Return on Equity (ROE)
- -0.61
- Return on Assets (ROA)
- -0.19
- Return on Invested Capital (ROIC)
- -25.22%
- Return on Capital Employed (ROCE)
- -0.27
- Revenue Per Employee
- 1.19M
- Profits Per Employee
- -538.06K
- Employee Count
- 464
- Asset Turnover
- 0.41
- Inventory Turnover
- 2.16
Valuation Ratios
The current PE Ratio of Shanghai MicroPort MedBot (Group) Co., Ltd. Class H is -75.13. Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s PEG ratio is -0.84.
- PE Ratio
- -75.13
- PS Ratio
- 33.53
- PB Ratio
- 45.27
- Price to FCF
- -550.58
- Price to Operating Cash Flow
- -600.86
- PEG Ratio
- -0.84
Income Statement
In the last 12 months, Shanghai MicroPort MedBot (Group) Co., Ltd. Class H had revenue of 551.07M and earned -249.66M in profits. Earnings per share was -0.24.
- Revenue
- 551.07M
- Gross Profit
- 266.62M
- Operating Income
- -235.26M
- Pretax Income
- -254.12M
- Net Income
- -249.66M
- EBITDA
- -62.02M
- Earnings Per Share (EPS)
- -0.24
Cash Flow
In the last 12 months, operating cash flow was -30.95M and capital expenditures -2.61M, giving a free cash flow of -33.56M billion.
- Operating Cash Flow
- -30.95M
- Free Cash Flow
- -33.56M
- Free Cash Flow per Share
- -0.03
Dividends & Yields
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.18%
- Earnings Yield
- -1.34%
Stock Price Statistics
- Beta
- 3.72
- 52-Week Price Change
- 123.21%
- 50-Day Moving Average
- 3.75
- 200-Day Moving Average
- 3.26
- Relative Strength Index (RSI)
- 38.51
- Average Volume (3m)
- ―
Important Dates
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Mar 31, 2027
- Ex-Dividend Date
- ―
Financial Position
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H as a current ratio of 2.30, with Debt / Equity ratio of 103.78%
- Current Ratio
- 2.30
- Quick Ratio
- 2.01
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 3.45
- Interest Coverage Ratio
- -11.96
Taxes
In the past 12 months, Shanghai MicroPort MedBot (Group) Co., Ltd. Class H has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H EV to EBITDA ratio is -295.97, with an EV/FCF ratio of -543.29.
- EV to Sales
- 33.08
- EV to EBITDA
- -295.97
- EV to Free Cash Flow
- -543.29
- EV to Operating Cash Flow
- -589.03
Balance Sheet
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H has $640.42M in cash and marketable securities with $426.37M in debt, giving a net cash position of $214.05M billion.
- Cash & Marketable Securities
- $640.42M
- Total Debt
- $426.37M
- Net Cash
- $214.05M
- Net Cash Per Share
- $0.21
- Tangible Book Value Per Share
- $0.39
Margins
Gross margin is 48.38%, with operating margin of -42.69%, and net profit margin of -45.30%.
- Gross Margin
- 48.38%
- Operating Margin
- -42.69%
- Pretax Margin
- -46.11%
- Net Profit Margin
- -45.30%
- EBITDA Margin
- -11.18%
- EBIT Margin
- -31.03%
Analyst Forecast
The average price target for Shanghai MicroPort MedBot (Group) Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 115.04%
- EPS Growth Forecast
- 63.16%
Scores
- Smart Score
- 4
- AI Score
- ―

